Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Janssen

Showing results (141-150 of 203) with videos related to

Pageof 21
Sort By:
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|September 22, 2006
Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settingsBernard M Branson, H Hunter Handsfield, Margaret A Lampe, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1989
Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre studyS Negrier, T Philip, G Stoter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 29, 2000
Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San FranciscoW McFarland, M P Busch, T A Kellogg, et al.
Rheumatology International|January 1, 1988
AA amyloidosis associated with systemic lupus erythematosusE J ter Borg, S Janssen, M H van Rijswijk, et al.
Molecular and Biochemical Parasitology|June 1, 2005
The plastidic DNA replication enzyme complex of Plasmodium falciparumFiona Seow, Shigeharu Sato, Christoph S Janssen, et al.
Vaccine|June 4, 2013
Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of ageWilliam L Heyward, Michael Kyle, Joseph Blumenau, et al.
American Journal of Epidemiology|November 1, 1989
Multiple sclerosis in Key West, FloridaC G Helmick, J M Wrigley, M M Zack, et al.
Lancet (London, England)|December 14, 2002
Protease inhibitors and cardiovascular outcomes in patients with HIV-1Scott D Holmberg, Anne C Moorman, John M Williamson, et al.
Vaccine|June 4, 2013
Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney diseaseRobert S Janssen, Roberto Mangoo-Karim, Pablo E Pergola, et al.
Journal of Inherited Metabolic Disease|January 1, 1992
Paediatric cerebrotendinous xanthomatosisR A Wevers, J R Cruysberg, A F Van Heijst, et al.
Pageof 21

Showing results (141-150 of 203) with videos related to

Sort By:
Pageof 21
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|September 22, 2006
Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settingsBernard M Branson, H Hunter Handsfield, Margaret A Lampe, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1989
Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre studyS Negrier, T Philip, G Stoter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 29, 2000
Detection of early HIV infection and estimation of incidence using a sensitive/less-sensitive enzyme immunoassay testing strategy at anonymous counseling and testing sites in San FranciscoW McFarland, M P Busch, T A Kellogg, et al.
Rheumatology International|January 1, 1988
AA amyloidosis associated with systemic lupus erythematosusE J ter Borg, S Janssen, M H van Rijswijk, et al.
Molecular and Biochemical Parasitology|June 1, 2005
The plastidic DNA replication enzyme complex of Plasmodium falciparumFiona Seow, Shigeharu Sato, Christoph S Janssen, et al.
Vaccine|June 4, 2013
Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of ageWilliam L Heyward, Michael Kyle, Joseph Blumenau, et al.
American Journal of Epidemiology|November 1, 1989
Multiple sclerosis in Key West, FloridaC G Helmick, J M Wrigley, M M Zack, et al.
Lancet (London, England)|December 14, 2002
Protease inhibitors and cardiovascular outcomes in patients with HIV-1Scott D Holmberg, Anne C Moorman, John M Williamson, et al.
Vaccine|June 4, 2013
Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney diseaseRobert S Janssen, Roberto Mangoo-Karim, Pablo E Pergola, et al.
Journal of Inherited Metabolic Disease|January 1, 1992
Paediatric cerebrotendinous xanthomatosisR A Wevers, J R Cruysberg, A F Van Heijst, et al.
Pageof 21